Acquired, but Not Innate, Immune Responses toStreptococcus pneumoniaeAre Compromised by Neutralization of CD40L
Open Access
- 1 February 2000
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (2) , 511-517
- https://doi.org/10.1128/iai.68.2.511-517.2000
Abstract
Streptococcus pneumoniaeis a significant pathogen of young children and the elderly. Systemic infection by pneumococci is a complex process involving several bacterial and host factors. We have investigated the role of CD40L in host defense against pneumococcal infection. Treatment of mice with MR-1 antibody (anti-CD154/CD40L) markedly reduced antibody responses to the pneumococcal protein PspA, elicited by immunization of purified protein or whole bacteria. In mice immunized with whole bacteria, MR-1 treatment reduced antibody responses to capsular polysaccharides but not cell wall polysaccharides. MR-1 did not suppress antibody responses to isolated capsular polysaccharides but did reduce the production of antibody to a capsular polysaccharide-protein conjugate, indicating that when presented in the context of whole bacteria, the humoral response to capsular polysaccharides is partially T-cell dependent. Despite the reduction of the protective humoral responses to pneumococcal infection, administration of MR-1 had no effect on sepsis, lung infection, or nasal carriage in nonimmune mice inoculated with virulent pneumococci. Thus, short-term neutralization of CD40L does not compromise innate host defenses against pneumococcal invasion.Keywords
This publication has 65 references indexed in Scilit:
- C-POLYSACCHARIDE IN A PNEUMOCOCCAL VACCINEActa Pathologica Microbiologica Scandinavica Series C: Immunology, 2009
- Ligation of CD40 Activates Interleukin 1β-converting Enzyme (Caspase-1) Activity in Vascular Smooth Muscle and Endothelial Cells and Promotes Elaboration of Active Interleukin 1βJournal of Biological Chemistry, 1997
- PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in miceVaccine, 1996
- Protective Role of CD40 in Leishmania major Infection at Two Distinct Phases of Cell-Mediated ImmunityPublished by Elsevier ,1996
- Role of Lymphotoxin and the Type I TNF Receptor in the Formation of Germinal CentersScience, 1996
- Pathogenesis of Pneumococcal InfectionNew England Journal of Medicine, 1995
- Adjuvant Quil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccinesVaccine, 1994
- Mice deficient for the CD40 ligandPublished by Elsevier ,1994
- Hypogammaglobulinaemia associated with normal or increased IgM (the hyper IgM syndrome): a case series review.Archives of Disease in Childhood, 1994
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993